Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Ajanta Pharma Continues Growth
India PR Wire, India
Saturday, October 29, 2011 - 2:44pm
tags:
Ajanta Pharma
BioSante Pharmaceuticals Closes $48.0 Million Public Offering of Common Stock
Benzinga
Saturday, October 29, 2011 - 2:42pm
tags:
BioSante
Valeant Announces Take-Up of Additional Afexa Shares and Special Meeting of Shareholders of Afexa to Approve Its Privatization
Bradenton Herald, FL
Saturday, October 29, 2011 - 2:37pm
tags:
Valeant Pharmaceuticals, Afexa
Spectrum Pharmaceuticals
Yahoo/Investor's Business Daily
Saturday, October 29, 2011 - 2:25pm
tags:
Spectrum Pharmaceuticals
Bayer, The FDA & Confidential Yaz Documents
Pharmalot
Saturday, October 29, 2011 - 1:01pm
tags:
Bayer, birth control pill, Yaz, FDA
Vertex Bests Merck in New Hepatitis C Drug Sales
NY Times, NY
Saturday, October 29, 2011 - 12:55pm
tags:
hepatitis C, Merck, Vertex, Incivek, Victrelis
KV, Hermelin offer competing versions of blame for drugmaker's meltdown
St Louis Today, MO
Saturday, October 29, 2011 - 12:54pm
tags:
KV Pharmaceutical, Marc Hermelin
Don't Get Too Worked Up Over Illumina's Earnings
Motley Fool
Saturday, October 29, 2011 - 12:52pm
tags:
earnings, Illumina
Momenta: court blocks rivals from selling generic
Yahoo/AP
Saturday, October 29, 2011 - 12:51pm
tags:
Momenta, generics, Lovenox, Amphastar
A Mea Culpa: Spectrum's Fusilev Sales Are Growing Faster Than I Expected
TheStreet.com
Saturday, October 29, 2011 - 12:50pm
tags:
Spectrum Pharmaceuticals, Fusilev, colon cancer
Is ViroPharma's Growth for Real?
Motley Fool
Saturday, October 29, 2011 - 12:49pm
tags:
ViroPharma
Strong Quarter at Endo Pharma
Yahoo/Zacks.com
Saturday, October 29, 2011 - 12:48pm
tags:
earnings, Endo
Merck’s Vytorin Cuts Heart Risk in Kidney Patients, FDA Says
Bloomberg
Saturday, October 29, 2011 - 12:46pm
tags:
FDA, Vytorin, Merck, kidney disease
Biogen profits up 38 percent
Bizjournals.com
Friday, October 28, 2011 - 11:45am
tags:
earnings, Biogen Idec
Gilead asks FDA to approve blockbuster hopeful Quad against HIV
Fierce Biotech
Friday, October 28, 2011 - 11:27am
tags:
Gilead, FDA, Quad, HIV
[video] The Next Big Thing in Biotech: Pharmasset
TheStreet.com
Friday, October 28, 2011 - 11:25am
tags:
hepatitis C, Pharmasset, PSI-7977
Pradaxa hit with pre-treatment screening advice
Fierce Pharma
Friday, October 28, 2011 - 11:21am
tags:
Pradaxa, Boehringer Ingelheim, bloodthinners
Gilead 3rd-quarter profit rises on greater sales of HIV drugs, including the new Complera
Yahoo/AP
Friday, October 28, 2011 - 11:09am
tags:
HIV, Complera, earnings, Gilead
Theravance reports larger 3rd-quarter loss as lung disease drug research costs grow
Yahoo/AP
Friday, October 28, 2011 - 11:08am
tags:
earnings, Theravance
1 Biotech To Buy And 6 FDA Decision-Pending Biotechs To Avoid
Seeking Alpha
Friday, October 28, 2011 - 11:07am
tags:
Celgene, Pacira, Incyte, BioSante, Regeneron, Transcept, Antares

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.